Navigation Links
Auspex Initiates Phase 3 Trial of SD-809 in Huntington's Disease
Date:7/11/2013

LA JOLLA, Calif., July 11, 2013 /PRNewswire/ -- Auspex Pharmaceuticals announced today that the first patient has been enrolled in a multi-center Phase 3 pivotal trial of its lead investigational drug, SD-809 for the treatment of involuntary movements (chorea) associated with Huntington's Disease (HD). Top-line data from the trial, designated the First-HD study, are expected in 2014.

(Logo: http://photos.prnewswire.com/prnh/20130627/MM40068LOGO)

"SD-809 is a deuterated form of tetrabenazine with pharmacokinetic properties that allow for more consistent blood levels and less frequent dosing.  This may lead to improved medication compliance and patient outcomes," said David A. Stamler, MD, Auspex Chief Medical Officer. "We are enthusiastic to be conducting this study in partnership with the Huntington Study Group, an international network of experienced clinical trial investigators at leading academic centers that care for HD patients and families."

First-HD, or "First time use of SD-809 in HD", is a randomized, double-blind, placebo-controlled study that will test the efficacy, safety and tolerability of SD-809 in the management of chorea symptoms in 90 HD patients who have not previously taken tetrabenazine.  The primary endpoint for the study will be Total Maximal Chorea (TMC) score. Secondary endpoints will include treatment success measurements based on patient and clinical global impressions of change. Participants will be involved in this trial for approximately four months. In parallel with First-HD, Auspex will be conducting an open-label study of SD‑809 in experienced tetrabenazine users and subjects who complete First-HD (Alternatives for Reducing Chorea in HD or ARC-HD Trial).

Principal Investigators for the First-HD study are Dr. Samuel Frank at Boston
'/>"/>

SOURCE Auspex Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auspex Pharmaceuticals Receives U.S. Patent on Novel JAK Inhibitor SD-900
2. AtheroNova Initiates Phase 1 Clinical Trial of AHRO-001, a Potential Treatment for Atherosclerosis
3. Xenon Licenses Antisense Drug XEN701 From Isis and Initiates Preclinical Toxicology Studies
4. Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients
5. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
6. Soligenix Initiates Phase 1 Clinical Study with SGX203 for the Treatment of Pediatric Crohns Disease
7. Ambrx Initiates Collaboration with Bristol-Myers Squibb for Discovery, Development of Next-Generation Antibody Drug Conjugates
8. Acutus Medical, Inc. Initiates "First-In-Man" Clinical Study of Real-Time 3D Imaging Catheter with CT/MRI Quality
9. ISIS Pharmaceuticals Initiates a Clinical Study of ISIS-SMN Rx in Infants With Spinal Muscular Atrophy
10. Romark Laboratories Initiates Phase 3 Trial of New Influenza Drug
11. Savara Pharmaceuticals Initiates Phase 2 Clinical Trial of AeroVanc for MRSA Lung Infection in Cystic Fibrosis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Inc. (NASDAQ: UPI ), a medical device company ... treat voiding dysfunctions, today reported financial results for the ... Global revenue for the Company,s Urgent ®  PC Neuromodulation ... revenue record, as compared to $3.9 million in the ...
(Date:1/22/2015)... 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the ... therapies for cardiovascular disease and overall health is pleased to ... 2014 and its outlook for 2015 from the CEO, Mr. ... We would like to take this opportunity to share ...
(Date:1/22/2015)... MINNEAPOLIS , Jan. 22, 2015  Bio-Techne Corporation (NASDAQ: ... launched Ella, the first member of the new Simple ... ProteinSimple brand.  This launch represents the re-branding of the ... The Simple Plex platform is a transformative immunoassay technology ...
Breaking Medicine Technology:Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7Bio-Techne Launches Simple Plex Platform 2Bio-Techne Launches Simple Plex Platform 3
... DIEGO, Dec. 14, 2010 Aethlon Medical, Inc. (OTC ... developing therapeutic filtration devices to address infectious disease and ... to present at the U.S. Department of Health and ... 2011.  The Aethlon Medical presentation entitled: "A Broad Spectrum ...
... Calif., Dec. 14, 2010 Cell Biosciences, Inc. today ... and Devices for Analyte Detection" by the United States ... a key element of intellectual property related to NanoPro ... family directed towards the detection of specific proteins in ...
Cached Medicine Technology:Aethlon Medical Announces Presentation at U.S. Department of Health and Human Services BARDA Industry Day 2Aethlon Medical Announces Presentation at U.S. Department of Health and Human Services BARDA Industry Day 3Aethlon Medical Announces Presentation at U.S. Department of Health and Human Services BARDA Industry Day 4
(Date:1/22/2015)... has added many trendy Champagne wedding dresses to ... the past three years. Today, the business announces a special ... the sales manager of the company, this is on the ... point can be reflected on the discounted wedding dresses from ...
(Date:1/22/2015)... 2015 Four years since the release of their ... with the marriage of Avasa & Matthew Love – the duo ... scheduled for release through White Swan Records on February 24, 2015. ... a sacred path available to all of us to walk out ...
(Date:1/22/2015)... EBSCO Information Services (EBSCO) and the ... in an effort to further promote visibility and adoption of ... long made AMA journals available via its subscription services, EBSCO ... Network. , Long known as both a subscription ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 JJsHouse.com is a ... dresses. Today, the business announces its latest collection of ... , “The most important issue is the wedding dress on ... thing in a woman’s life. Every bride wants to find ...
(Date:1/22/2015)... 22, 2015 Lower-Auto-Insurance.com has released a new blog ... a car for reducing the costs of an auto insurance ... be able to get lower prices for their vehicle insurance policies. ... role in determining policy costs. Because of this, drivers should ...
Breaking Medicine News(10 mins):Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2
... By Madonna Behen HealthDay Reporter , THURSDAY, Feb. ... exercise can help lower the risk of stroke, but a ... have better odds of recovery if they do suffer a ... more physically active before a stroke responded much better to ...
... The Scripps Research Institute, Scripps Health, and collaborating ... an advanced blood test for detecting and analyzing ... tumorsfrom cancer patients. The findings, reported in five ... analysis provides information that may soon be comparable ...
... YORK, February 2, 2012 Postmenopausal women may be at ... A new study by researchers at NYU Langone Medical ... such as high cholesterol are not as accurate ... researchers say doctors should refocus their attention on triglyceride levels ...
... , THURSDAY, Feb. 2 (HealthDay News) -- The sale ... United States, but the small reptiles are still available and ... warns. Because of the health danger, pet turtles are ... people, such as pregnant women, seniors and those with weak ...
... QR Codes," a Penn State project that allows hospital patients ... bad -- in real time, is the winner of the ... the Health 2.0 Developer Challenge. "As a former health care ... taking so long to see a doctor, and I have ...
... drug oxaliplatin is a major reason the prognosis for metastatic ... months to a couple years. Unfortunately, the drug can also ... as the sensation of pins and needles in fingers and ... independently. However, "Many patients don,t receive the necessary dose ...
Cached Medicine News:Health News:Being Fit Before Stroke May Aid Recovery 2Health News:Being Fit Before Stroke May Aid Recovery 3Health News:Scripps research scientists demonstrate effective new 'biopsy in a blood test' to detect cancer 2Health News:Scripps research scientists demonstrate effective new 'biopsy in a blood test' to detect cancer 3Health News:Scripps research scientists demonstrate effective new 'biopsy in a blood test' to detect cancer 4Health News:Triglyceride levels predict stroke risk in postmenopausal women 2Health News:Pet Turtles Carry Salmonella Dangers, CDC Warns 2Health News:Penn State team's QR code wins REACH Challenge 2Health News:Penn State team's QR code wins REACH Challenge 3Health News:Balancing oxaliplatin dose with neurological side effects in metastatic colon cancer 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: